The FDA said July 20 that Baxter International Inc. is voluntarily recalling two lots of intravenous (IV) solutions to the hospital/user level due to the potential presence of particulate matter.
The recall is for sodium chloride injections, in both plastic containers and mini-bag containers.
The Food and Drug Administration said in an online posting that the particulate matter in each case was determined to be an insect and was identified as a result of a customer complaint. “The matter was identified prior to patient administration and there have been no adverse events associated with this issue reported to Baxter,” the ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.